MA25652A1 - Monohydrate de cis-lithium-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate - Google Patents

Monohydrate de cis-lithium-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate

Info

Publication number: MA25652A1
Authority: MA; Morocco
Prior art keywords: cyclohexanecarboxylate; cyclopentyloxy; monohydrate; cis; cyano
Prior art date: 2000-01-26

Application number

MA26744A

Other languages

English (en)

Inventor

Kevin Scott Webb

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-26

Filing date

2002-07-24

Publication date

2002-12-31

2002-07-24 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2002-12-31 Publication of MA25652A1 publication Critical patent/MA25652A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hospice & Palliative Care (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MA26744A 2000-01-26 2002-07-24 Monohydrate de cis-lithium-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate MA25652A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US17812900P	2000-01-26	2000-01-26

Publications (1)

Publication Number	Publication Date
MA25652A1 true MA25652A1 (fr)	2002-12-31

Family

ID=22651319

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26744A MA25652A1 (fr)	2000-01-26	2002-07-24	Monohydrate de cis-lithium-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate

Country Status (36)

Country	Link
US (1)	US6699903B2 (fr)
EP (1)	EP1250313B1 (fr)
JP (1)	JP2003520842A (fr)
KR (1)	KR20020073183A (fr)
CN (1)	CN1157371C (fr)
AP (1)	AP1432A (fr)
AR (1)	AR027273A1 (fr)
AT (1)	ATE344235T1 (fr)
AU (1)	AU3282201A (fr)
BG (1)	BG106959A (fr)
BR (1)	BR0107709A (fr)
CA (1)	CA2397758A1 (fr)
CO (1)	CO5300517A1 (fr)
CY (1)	CY1108515T1 (fr)
CZ (1)	CZ20022590A3 (fr)
DE (1)	DE60124221T2 (fr)
DK (1)	DK1250313T3 (fr)
DZ (1)	DZ3285A1 (fr)
EA (1)	EA200200791A1 (fr)
EG (1)	EG24065A (fr)
ES (1)	ES2273804T3 (fr)
HK (1)	HK1051030A1 (fr)
HU (1)	HUP0204150A3 (fr)
IL (1)	IL150400A0 (fr)
MA (1)	MA25652A1 (fr)
MX (1)	MXPA02007300A (fr)
MY (1)	MY122802A (fr)
NO (1)	NO20023378D0 (fr)
NZ (1)	NZ519799A (fr)
OA (1)	OA12159A (fr)
PE (1)	PE20011040A1 (fr)
PL (1)	PL356832A1 (fr)
PT (1)	PT1250313E (fr)
SK (1)	SK10942002A3 (fr)
WO (1)	WO2001055094A1 (fr)
ZA (1)	ZA200205925B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0011802D0 (en) *	2000-05-16	2000-07-05	Smithkline Beecham	Method for enhancing cognitive function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI944549L (fi) *	1992-04-02	1994-11-30	Smithkline Beecham Corp	Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet
UA67753C2 (uk) *	1997-10-10	2004-07-15	Смітклайн Бічам Корпорейшн	Спосіб отримання заміщених 4-феніл-4-ціанциклогексанових кислот

2001
- 2001-01-18 EP EP01904886A patent/EP1250313B1/fr not_active Expired - Lifetime
- 2001-01-18 KR KR1020027009545A patent/KR20020073183A/ko not_active Ceased
- 2001-01-18 EA EA200200791A patent/EA200200791A1/ru unknown
- 2001-01-18 SK SK1094-2002A patent/SK10942002A3/sk unknown
- 2001-01-18 HK HK03101828.3A patent/HK1051030A1/zh unknown
- 2001-01-18 MX MXPA02007300A patent/MXPA02007300A/es active IP Right Grant
- 2001-01-18 HU HU0204150A patent/HUP0204150A3/hu unknown
- 2001-01-18 AT AT01904886T patent/ATE344235T1/de not_active IP Right Cessation
- 2001-01-18 US US10/181,865 patent/US6699903B2/en not_active Expired - Fee Related
- 2001-01-18 NZ NZ519799A patent/NZ519799A/en unknown
- 2001-01-18 BR BR0107709-0A patent/BR0107709A/pt not_active IP Right Cessation
- 2001-01-18 WO PCT/US2001/001487 patent/WO2001055094A1/fr not_active Ceased
- 2001-01-18 DE DE60124221T patent/DE60124221T2/de not_active Expired - Lifetime
- 2001-01-18 DK DK01904886T patent/DK1250313T3/da active
- 2001-01-18 CN CNB018040160A patent/CN1157371C/zh not_active Expired - Fee Related
- 2001-01-18 AP APAP/P/2002/002566A patent/AP1432A/en active
- 2001-01-18 IL IL15040001A patent/IL150400A0/xx unknown
- 2001-01-18 PL PL01356832A patent/PL356832A1/xx not_active IP Right Cessation
- 2001-01-18 CZ CZ20022590A patent/CZ20022590A3/cs unknown
- 2001-01-18 PT PT01904886T patent/PT1250313E/pt unknown
- 2001-01-18 JP JP2001555036A patent/JP2003520842A/ja not_active Withdrawn
- 2001-01-18 DZ DZ013285A patent/DZ3285A1/fr active
- 2001-01-18 OA OA1200200211A patent/OA12159A/en unknown
- 2001-01-18 CA CA002397758A patent/CA2397758A1/fr not_active Abandoned
- 2001-01-18 ES ES01904886T patent/ES2273804T3/es not_active Expired - Lifetime
- 2001-01-18 AU AU32822/01A patent/AU3282201A/en not_active Abandoned
- 2001-01-23 MY MYPI20010322A patent/MY122802A/en unknown
- 2001-01-24 EG EG20010070A patent/EG24065A/xx active
- 2001-01-24 AR ARP010100298A patent/AR027273A1/es unknown
- 2001-01-25 PE PE2001000081A patent/PE20011040A1/es not_active Application Discontinuation
- 2001-01-26 CO CO01005892A patent/CO5300517A1/es not_active Application Discontinuation
2002
- 2002-07-12 NO NO20023378A patent/NO20023378D0/no not_active Application Discontinuation
- 2002-07-24 ZA ZA200205925A patent/ZA200205925B/en unknown
- 2002-07-24 MA MA26744A patent/MA25652A1/fr unknown
- 2002-07-26 BG BG106959A patent/BG106959A/xx unknown
2007
- 2007-01-10 CY CY20071100034T patent/CY1108515T1/el unknown

Also Published As

Publication number	Publication date
NZ519799A (en)	2004-04-30
CA2397758A1 (fr)	2001-08-02
DK1250313T3 (da)	2007-02-12
OA12159A (en)	2006-05-08
PL356832A1 (en)	2004-07-12
AR027273A1 (es)	2003-03-19
AP2002002566A0 (en)	2002-06-30
KR20020073183A (ko)	2002-09-19
MY122802A (en)	2006-05-31
ATE344235T1 (de)	2006-11-15
CO5300517A1 (es)	2003-07-31
EP1250313A1 (fr)	2002-10-23
CY1108515T1 (el)	2014-04-09
AP1432A (en)	2005-06-20
JP2003520842A (ja)	2003-07-08
NO20023378L (no)	2002-07-12
BG106959A (en)	2003-05-30
US6699903B2 (en)	2004-03-02
CN1157371C (zh)	2004-07-14
EG24065A (en)	2008-05-08
BR0107709A (pt)	2002-11-19
HUP0204150A2 (hu)	2003-04-28
WO2001055094A1 (fr)	2001-08-02
HK1051030A1 (zh)	2003-07-18
ZA200205925B (en)	2003-11-21
DZ3285A1 (fr)	2001-08-02
MXPA02007300A (es)	2002-11-29
SK10942002A3 (sk)	2002-11-06
HUP0204150A3 (en)	2003-05-28
PT1250313E (pt)	2007-01-31
US20030032670A1 (en)	2003-02-13
EP1250313B1 (fr)	2006-11-02
PE20011040A1 (es)	2001-10-31
NO20023378D0 (no)	2002-07-12
AU3282201A (en)	2001-08-07
DE60124221T2 (de)	2007-09-13
EP1250313A4 (fr)	2005-09-21
IL150400A0 (en)	2002-12-01
EA200200791A1 (ru)	2002-12-26
CZ20022590A3 (cs)	2003-01-15
DE60124221D1 (de)	2006-12-14
CN1395556A (zh)	2003-02-05
ES2273804T3 (es)	2007-05-16

Publication	Publication Date	Title
DZ3409A1 (fr)	2002-02-21	Association therapeuthique
LU91584I2 (fr)	2009-09-10	Ustekinumab (Stelara)
PT1406628E (pt)	2006-06-30	Derivados de tera-hidroquinolina
DK1199054T3 (da)	2004-09-27	Væskefrakturhånddel
EP1374310A4 (fr)	2008-02-20	Nanofabrication
DE60115555D1 (de)	2006-01-12	Funduskamera
ATE312827T1 (de)	2005-12-15	3-substituierte-4-pyrimidonderivate
DE60106800D1 (de)	2004-12-09	Funduskamera
DE60133147D1 (de)	2008-04-17	Zylinder
DE60231527D1 (de)	2009-04-23	Aerosolspritzdüse
DE10196135T1 (de)	2003-03-27	Port-Paket-Warteschlangenbildung
DE50209245D1 (de)	2007-02-22	Neuroprotektives medikament
DE50100088D1 (de)	2003-02-27	Irisblende
DE60128315D1 (de)	2007-06-21	Funduskamera
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate
DE60108161D1 (de)	2005-02-03	Halo-krone
DE60215562D1 (de)	2006-12-07	Bogendruckmaschine
DE10193450D2 (de)	2003-10-02	Gehörschutzstöpsel
FI20010894A0 (fi)	2001-04-27	Kaksiosainen laite
DE60233352D1 (de)	2009-09-24	Modulus-zwei-vorskaliererschaltung
DZ3285A1 (fr)	2001-08-02	Monohydrate cis-lithium-4-cyano-4-(3-(cyclopentyloxy)-4methoxyphenyl) cyclohexanecarboxylate
DE60202381D1 (de)	2005-01-27	Paroxetin-n-formyl-derivate
DE10062626B4 (de)	2005-10-20	Infektionsmodelle
ATA7642000A (de)	2000-11-15	Kopfband
ATE348799T1 (de)	2007-01-15	Substituierte cyclohexanderivate